TPCA-1 - CAS# 507475-17-4 olet gov/books/NBK548002/ PubMed PMID: 31643334

gov/books/NBK548002/ PubMed PMID: 31643334

InChi: InChI=1S/C21H24N2O2/c1-13(2)22-9-10-23-20-7-5-16(14(3)24)11-18(20)19-12-17(15(4)25)6-8-21(19)23/h5-8

Cisatracurium (formerly recognized as 51W89

309(3):E302-10

inhibits tumor growth in vivo

TPCA-1 - CAS# 507475-17-4 olet gov/books/NBK548002/ PubMed PMID: 31643334TPCA 1 is a potent IKK 2 inhibitor. TPCA 1 is also an effective inhibitor of STAT3 phosphorylation, DNA binding, and transactivation in vivo. It selectively repressed proliferation of NSCLC cells with constitutive STAT3 activation. TPCA 1 as a direct dual inhibitor for both IKKs and STAT3, whereas treatment targeting EGFR only could not sufficiently repress NF B and STAT3 pathways for lung cancers harboring mutant EGFR. Therefore, synergistic